Skip to Content


President Bush Names Dr. Kripke to National Cancer Panel

President Bush Names Dr. Kripke to National Cancer Panel
M. D. Anderson News Release 03/21/03

President George W. Bush recently announced his intention to appoint Margaret Kripke, Ph.D., executive vice president and chief academic officer at The University of Texas M. D. Anderson Cancer Center, to the President’s Cancer Panel.

Kripke will serve a three-year term expiring Feb. 20, 2006. The three-person panel reports directly to the president on progress and problems in the nation’s effort to reduce the burden of cancer.

Kripke, who joined the M. D. Anderson faculty in 1983, is an internationally-recognized authority in the fields of tumor immunology and photobiology. She has contributed significantly to a better understanding of the immune response against cancer and how cancer cells can evade destruction by their host. Her research has demonstrated that skin cancers induced by chronic exposure to UV radiation are highly antigenic, and that the survival of these tumors in the host is due to systemic immune alterations caused by UV radiation.

Kripke joins Lance Armstrong, a testicular cancer survivor and Olympic gold medal cyclist, and panel chair LaSalle D. Leffall, Jr., M.D., professor of surgery at Howard University, on the panel. According to the White House, members are chosen “by virtue of their training, experience and background and are exceptionally qualified to appraise the National Cancer Program.” At least four public meetings are held annually to review the strategic plans, goals and achievements of the National Cancer Program, and to identify delays or barriers to its rapid implementation.

Former M. D. Anderson President R. Lee Clark, M.D. was a member of the original panel, appointed by President Richard Nixon, after the panel was established by the National Cancer Act of 1971.

“We are delighted that Dr. Kripke has been appointed to the President’s Cancer Panel both for the honor it brings to her and M. D. Anderson, and because she will have the opportunity to advise the president on priorities and strengths that will speed up the effort to reduce mortality from cancer,” said M. D. Anderson President John Mendelsohn, M.D. “Her many years as a scientist at the forefront of cancer research and her broad experience at the nation’s leading cancer center, with its strong translational, clinical and prevention research programs, will be helpful in setting the future agenda for cancer research and care in the United States.”

A native of California, Kripke received her Ph.D. in immunology from the University of California at Berkeley and completed postdoctoral work at Ohio State University. After three years on the University of Utah faculty, she joined the National Cancer Institute – Frederick Cancer Research Facility, where she advanced to director of the Cancer Biology Program.
After joining M. D. Anderson in 1983 as professor and founding chair of the Department of Immunology, she entered administration in 1998 as vice president for academic programs. She was promoted to senior vice president in 1999 and executive vice president in 2001. 

As executive vice president and chief academic officer, Kripke is responsible for M. D. Anderson’s research and educational programs, as well as all issues related to faculty recruitment and development. Research expenditures in 2002 totaled more than $262 million, and there are more than 850 faculty at M. D. Anderson.


© 2015 The University of Texas MD Anderson Cancer Center